188 related articles for article (PubMed ID: 33527765)
1. MiRNA-145-5p expression and prospective molecular mechanisms in the metastasis of prostate cancer.
Huang ZG; Sun Y; Chen G; Dang YW; Lu HP; He J; Cheng JW; He ML; Li SH
IET Syst Biol; 2021 Feb; 15(1):1-13. PubMed ID: 33527765
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miRNA-205 Expression and Biological Mechanism in Prostate Cancer Tumorigenesis and Bone Metastasis.
Sun Y; Li SH; Cheng JW; Chen G; Huang ZG; Gu YY; Yan HB; He ML
Biomed Res Int; 2020; 2020():6037434. PubMed ID: 33178832
[TBL] [Abstract][Full Text] [Related]
3. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
4. Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
Ma H; Wang LY; Yang RH; Zhou Y; Zhou P; Kong L
J Cell Biochem; 2019 Oct; 120(10):17779-17790. PubMed ID: 31127646
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
6. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y
Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834
[TBL] [Abstract][Full Text] [Related]
7. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
[TBL] [Abstract][Full Text] [Related]
8. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer.
Zhang Y; Jiang F; He H; Ye J; Mao X; Guo Q; Wu SL; Zhong W; Wu CL; Lin N
Cell Death Dis; 2018 Feb; 9(3):301. PubMed ID: 29467540
[TBL] [Abstract][Full Text] [Related]
10. Clinical Value and Potential Mechanism of miRNA-33a-5p in Lung Squamous Cell Carcinoma.
Wang XM; Chen SW; Chen G; Zhou HF; Gan TQ; Zeng JJ; Li ZY
Anal Cell Pathol (Amst); 2021; 2021():6614331. PubMed ID: 34888137
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and potential molecular mechanism of miRNA-222-3p in metastatic prostate cancer.
Sun Y; Chen G; He J; Huang ZG; Li SH; Yang YP; Zhong LY; Ji SF; Huang Y; Chen XH; He ML; Wu H
Bioengineered; 2021 Dec; 12(1):325-340. PubMed ID: 33356818
[TBL] [Abstract][Full Text] [Related]
12. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
14. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
[No Abstract] [Full Text] [Related]
15. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
Ye Y; Li SL; Wang SY
PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.
Fu Q; Liu X; Liu Y; Yang J; Lv G; Dong S
Int J Mol Med; 2015 Nov; 36(5):1417-25. PubMed ID: 26647850
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1.
Chen JY; Xu LF; Hu HL; Wen YQ; Chen D; Liu WH
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):639-646. PubMed ID: 32017004
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer.
Liu J; Li J; Ma Y; Xu C; Wang Y; He Y
Bioengineered; 2021 Dec; 12(1):3240-3251. PubMed ID: 34238129
[TBL] [Abstract][Full Text] [Related]
19. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor miRNA-204-5p promotes apoptosis by targeting BCL2 in prostate cancer cells.
Lin YC; Lin JF; Tsai TF; Chou KY; Chen HE; Hwang TI
Asian J Surg; 2017 Sep; 40(5):396-406. PubMed ID: 27519795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]